Read: Rishi will fight to reduce healthcare costs and supports Medicare for All, while Eshoo wants to privatize Medicare
The immediate economic fallout from the COVID-19 pandemic has been devastating in the United States and has exposed one of the biggest problems facing the American people - the state of American healthcare. For many - 160 million people - health insurance is tied to employment and losing a job may mean losing insurance.
Health and Human Services Secretary Alex Azar when asked about affordability of treatment for Covid-19, “ We would want to ensure that we work to make it affordable, but we can’t control that price because we need the private sector to invest. The priority is to get vaccines and therapeutics. Price controls won’t get us there.” Now, that could become a problem for America.
Healthcare costs have become a significant burden for our working families, more so during the pandemic, and are a major cause of bankruptcies for American families. It is time we explored better, cheaper healthcare options for the American people. As your Congressman, I will push for healthcare reform. I will fight back against burgeoning healthcare costs and rising drug prices. A single payer does not mean that we have a compromised healthcare system; many developed nations of the world have a high quality single payer system. America can too!
Rep. Eshoo does not support Medicare for All - and is not with the 118 Congressional Representatives who today support Medicare for All - including many from the Bay Area.I support Medicare for All (H.R 1384), which would guarantee affordable healthcare to everyone in this country, and the Bring Drug Prices Down Act (H.R 1046), which allows Medicare to negotiate drug prices with pharmaceutical companies.
Big Pharma and health lobbyists have penetrated their way into our government. My opponent, Rep. Anna Eshoo, chairs the House Health Subcommittee and is the number one recipient of Pharma money in the United States Congress. I have taken the pledge to never accept any special interest money or PAC money.